Introduction {#sec1}
============

*Clostridium niameyense* strain MT5 (= CSUR P1468 = DSMZ 100441) is the type strain of *C. niameyense* sp. nov. This bacterium is a Gram-positive, anaerobic, motile bacterium that was isolated from the stool of an anorexic patient with marasmus living in Nigeria as part of a culturomics study aiming at cultivating all species individually within human faeces [@bib1], [@bib2].

The usual parameters used to delineate a bacterial species include 16S rDNA sequence identity and phylogeny [@bib3], genomic G + C content diversity and DNA-DNA hybridization [@bib3]. Recently a new approach has been proposed, taxonogenomics, which includes genomic data in a polyphasic taxonomy to describe new bacterial species [@bib4]. This strategy is based on a combination of genomic and phenotypic characteristics, including matrix-assisted desorption ionization--time of flight mass spectrometry (MALDI-TOF MS) as well as spectrum and genomic analyses [@bib5].

*Clostridium* is a genus of Gram-positive bacteria which includes several significant human pathogens and consists of obligate anaerobic bacteria [@bib6]. These bacteria are the cause of some human diseases such as botulism (*C. botulinum*), tetanus (*C. tetani*), pseudomembranous colitis (*C. difficile*) and food poisoning--gas gangrene (*C. perfringens*) [@bib7]. The pathogenic clostridial species have evolved several mechanisms to survive inside and outside a number of hosts, as evidenced by various diseases often linked to their protein toxins and spores [@bib8].

Here we present a summary classification and set of features for *C. niameyense* sp. nov. strain MT5 together with the description of the complete genome sequence and annotation. These characteristics support the circumscription of the species *C. niameyense.*

Phenotypic and biochemical characterization {#sec2}
===========================================

*Clostridium niameyense* sp. nov. strain MT5 was isolated from a faecal sample collected from an anorexic patient with marasmus living in Nigeria. The faecal specimen was preserved at −80 °C after collection and sent to Marseille. The MT5 strain was cultivated on 5% sheep\'s blood--enriched Columbia agar (bioMérieux, Marcy l'Etoile, France) after 5 days\' preincubation in a blood culture bottle with rumen fluid.

For the growth of *C. niameyense,* we tested different temperatures (25, 30, 37 °C). However, optimal growth occurred at 37 °C, 24 hours after inoculation. Colonies were opaque with a smooth aspect, irregular and 1 mm in diameter on blood-enriched Columbia agar. Growth was observed only under anaerobic conditions, and no growth occurred under aerobic or microaerophilic conditions. Gram staining revealed a Gram-positive nonsporulating bacillus; the motility test was positive ([Fig. 1](#fig1){ref-type="fig"}).Fig. 1(a) Gram staining of *Clostridium niameyense* strain MT sp. (b) Transmission electron microscopy of *Clostridium niameyense* sp. nov. strain MT5 using TechnaiG^2^ Cryo device (FEI Company, Limeil-Brévannes, France) at operating voltage of 200 keV. Scale bar = 200 nm.

The obtained colonies were identified using a Microflex spectrometer (Bruker Daltonics, Bremen, Germany). MALDI-TOF MS identification, measurement and analysis were performed as previously described [@bib1]. No significant MALDI-TOF MS score was obtained for strain MT5 against the Bruker database, suggesting that our isolate was not a member of a known species. We added the spectrum from strain MT5 to our database ([Fig. 2](#fig2){ref-type="fig"}).Fig. 2Phylogenetic tree highlighting position of *Clostridium niameyense* sp. nov. strain MT5 relative to other type strains within *Clostridium* genus. GenBank accession numbers are indicated in parentheses. Sequences were aligned using CLUSTALW and phylogenetic inferences obtained using maximum-likelihood method within MEGA software.

Biochemical features of the strains were determined using API50-CHL and the API ZYM (bioMérieux). Oxydase (Becton Dickinson, Pont-de-Claix, France) and catalase assays (bioMérieux) were performed separately. API ZYM presented positive reactions for α-glucosidase (maltase) and β-glucosidase (cellulase). The differential phenotypic characteristics with other *Clostridium* species are summarized in [Table 1](#tbl1){ref-type="table"}.Table 1Differential characteristics of *Clostridium niameyense, C. beijerinckii* strain NCIMB 8052, *C. disporicum* NCIB12424, *C. carboxidivorans* strain P7, *C. dakarense* strain FF1, *C. difficile* strain B1 and *C. saudii* JCCTProperty*C. niameyenseC. beijerinckiiC. disporicumC. carboxidivoransC. dakarenseC. difficileC. saudii*Cell diameter (μm)11.71.51.51.23.01.0Oxygen requirementStrictly anaerobicStrictly anaerobicStrictly anaerobicStrictly anaerobicStrictly anaerobicStrictly anaerobicStrictly anaerobicGram strainpositiveVariablePositivePositivePositivePositivePositiveMotilityMotileMotileNAMotileMotileMotileMotileEndospore trainingNA+NA++++Indole−NA−−+NA−Production of:Alkaline phosphatase−NANANA+NA−Catalase−−−−−NA−Oxidase−NANA−−NA−Nitrate reduction−−NA−−−−Urease−−NA−−NA−β-Galactosidase+NANANA−NA−*N*-Acetyl-glucosamine−NANANANA−Acid from:[l]{.smallcaps}-Arabinose−+NA+−−−Ribose−−++−−−Mannose++++−+−Mannitol++++−+−Sucrose−+++−+−[d-]{.smallcaps}Glucose+++++NA−[d-]{.smallcaps}Fructose++++−+−[d-]{.smallcaps}Maltose−++++−−[d-]{.smallcaps}Lactose−+++−−−G+C satisfied (%)27.4428293127.982828HabitatHuman gutHuman gutRat gutEnvironmentHuman gutHuman gutHuman gut[^1]

Antibiotic susceptibility of our isolate was assessed using the disc diffusion method on Muller-Hinton agar plates supplemented with 5% blood (bioMérieux) using the standard disc diffusion procedure as recommended by the European Committee on Antimicrobial Susceptibility Testing (EUCAST; <http://www.eucast.org/>). *C. niameyense* was likely resistant to penicillin (14 mm), amoxicillin (13 mm), trimethoprim/sulfamethoxazole (6 mm), colistin (6 mm) and metronidazole (6 mm) but susceptible to vancomycin (22 mm), ertapenem (20 mm), fosfomycin (27 mm), teicoplanin (19 mm), oxacillin (22 mm), cefotaxime (20 mm), rifampicin (25 mm), gentamycin (27 mm), doxycycline (25 mm), pristinamycin (22 mm), erythromycin (26 mm), lincomycin (27 mm), imipenem (22 mm), tazocillin (24 mm), ofloxacin (25 mm), meropenem (20 mm) and ciprofloxacin (19 mm).

16S rRNA gene sequencing and phylogenetic analyses {#sec3}
==================================================

The organism was selected for sequencing on the basis of its phylogenetic position and 16S rRNA similarity to members of the genus *Clostridium* [@bib9] and is part of a study of the human digestive flora aiming to isolate all bacterial species in human faeces [@bib1]. A phylogenetic tree was constructed using the maximum-likelihood method in the MEGA6 software package (<https://www.megasoftware.net/>). Phylogenetic analysis of the complete sequence of the 16S rRNA gene of *C. niameyense* strain MT5 (= CSUR P1468 = DSMZ 100441) exhibited a 98.3% nucleotide sequence similarity with *Clostridium* *botulinum* A (L37585). This value was lower than the 98.7% 16S rRNA gene sequence threshold recommended by Stackebrandt and Ebers [@bib10] to delineate a new species without carrying out DNA-DNA hybridization ([Fig. 3](#fig3){ref-type="fig"}).Fig. 3Reference mass spectrum from *C. Clostridium niameyense* sp. nov. strain MT5. Spectra from 12 individual colonies were compared and reference spectrum generated.

Genome properties {#sec3.1}
-----------------

The genome is 2 542 841 bp long with 27.44% G+C content ([Table 2](#tbl2){ref-type="table"}). It is composed of six scaffolds (composed of seven contigs). Of the 2489 predicted genes, 2410 were protein-coding genes and 79 were RNAs (five genes are 5S rRNA, one gene is 16S rRNA, two genes are 23S rRNA and 71 genes are tRNA genes). A total of 1790 genes (74.27%) were assigned a putative function by Clusters of Orthologous Groups database (COGs) or by NR BLAST. Fifty-nine genes were identified as ORFans (2.45%). The remaining genes were annotated as hypothetical proteins (401 genes, \>16.64%). The properties of the genome are summarized in [Table 2](#tbl2){ref-type="table"}. A genomic comparison of *C. niameyense* with seven other *Clostridium* species is provided in [Table 3](#tbl3){ref-type="table"}. The distribution of genes into COGs functional categories is presented in [Table 4](#tbl4){ref-type="table"} ([Fig. 4](#fig4){ref-type="fig"}). The genome was assembled and annotated by Xegen (<http://www.xegen.fr/>).Fig. 4Graphical circular map of chromosome. From outside to centre: genes on forward strand coloured by COGs categories (only genes assigned to COGs), genes on reverse strand coloured by COGs categories (only gene assigned to COGs), RNA genes (tRNAs green, rRNAs red), G+C content and G+C skew. COGs, Clusters of Orthologous Groups database.Table 2Nucleotide content and gene count levels of genomeAttributeValue% of totalGenome size (bp)2 542 841100No. of G+C (bp)697 77227.44Genes2489100Protein genes241096.82RNA genes793.17tRNA genes712.85RNA (5S, 16S, 23S) genes80.32Coding sequence size2 232 88687.81Coding sequence gene protein size2 219 51487.28Coding sequence tRNA gene size55580.21Coding sequence (5S, 16S, 23S) genes size78140.307Protein-coding gene2410100Table 3Genomic comparison of *C. niameyense* with seven other *Clostridium* speciesSpeciesStrainGenome accession numberGenome size (Mb)G+C content*C. niameyense*MT5CVPI000000002.5427.4*C. perfringens*ATCC 13124ATCC 131243.2628.4*C. difficile*B1[NC_017179](ncbi-n:NC_017179){#intref0030}4.4628.4*C. dakarense*FF1CBTZ0100000003.7327.9*C. leptum*DSM753ABCB020000003.2750.2*C. botulinum*ATCC 3502[NC_009495](ncbi-n:NC_009495){#intref0035}3.9028.2*C. beijerinckii*NCIMB 8052[NC_009617](ncbi-n:NC_009617){#intref0040}6.029.0*C. senegalense*DSM 25507CAEV010000013.8926.8Table 4Number of genes associated with 25 general COGs functional categoriesCodeValue% of totalDescriptionJ1526.3070545TranslationA00RNA processing and modificationK1385.726141TranscriptionL994.107884Replication, recombination and repairB10.041493777Chromatin structure and dynamicsD271.120332Cell cycle control, mitosis and meiosisY00Nuclear structureV532.19917Defense mechanismsT974.0248966Signal transduction mechanismsM813.360996Cell wall/membrane biogenesisN602.4896266Cell motilityZ00CytoskeletonW00Extracellular structuresU371.5352697Intracellular trafficking and secretionO562.3236516Posttranslational modification, protein turnover, chaperonesC953.9419088Energy production and conversionG833.4439836Carbohydrate transport and metabolismE1385.726141Amino acid transport and metabolismF602.4896266Nucleotide transport and metabolismH753.1120331Coenzyme transport and metabolismI441.8257263Lipid transport and metabolismP873.6099586Inorganic ion transport and metabolismQ240.9958507Secondary metabolites biosynthesis, transport and catabolismR2088.630706General function prediction onlyS1606.6390047Function unknown---81233.692947Not in COGs[^2]

Genome annotation {#sec3.2}
-----------------

The ARG-ANNOT database for acquired antibiotic resistance genes (ARGs) was used for a BLAST search using the Bio-Edit interface. The assembled sequences were searched against the ARG database under moderately stringent conditions (*E* value of 10^−5^) for the *in silico* ARG prediction [@bib11]. The results obtained by ARG-ANNOT demonstrated that there are no known antibiotic-resistance genes in the genome of *C. niameyense* strain MT5.

These sequences were submitted to Rapid Annotation Using Subsystem Technology (RAST) [@bib12]. An exhaustive search of the bacteriocin database available in our laboratories (Bacteriocins of the URMITE, BUR; <http://drissifatima.wix.com/bacteriocins>) was performed by collecting all currently available sequences from the databases and from the National Center for Biotechnology Information. Protein sequences from this database allowed putative bacteriocins from human gut microbiota to be identified using BLASTp methodology [@bib13]. The analysis of the resistome did not identify antibiotic resistance genes, and the absence of bacteriocin was confirmed.

Analysis of the presence of polyketide synthases and nonribosomal peptide synthetases was performed by discriminating the genes with large sizes using a database realized in our laboratory; predicted proteins were compared against the nonredundant GenBank database using BLASTp and finally examined using antiSMASH [@bib14].

Analysis revealed five clusters of clusters of differentiation (CDs) (11 642 bp) predicted to code for enzymes involved in the nonribosomal synthesis of peptides ([Fig. 5](#fig5){ref-type="fig"}), which in turn were predicted to catalyze the synthesis of a siderophore ([Fig. 5](#fig5){ref-type="fig"}), which could be used under iron-deficient growth conditions.Fig. 5CDS clusters predicted to encode siderophore biosynthesis nonribosomal peptide synthetase. A, C, ACPS and TE are domains of nonribosomal peptide synthetases. A, AMP binding, adenylation domain; C, heterocyclization; TE, thioesterase domain.

This mechanism is already known in *Clostridium* spp., particularly in in *C. kluyveri* DSM555. The alignment of nonribosomal synthesis in *C. kluyveri* DSM555 (WP_012101903.1) and *C. niameyense* MT5 (WP_050607297.1) showed a 31% similarity with 99% coverage.

Description of *Clostridium niameyense* sp. nov. strain MT5 {#sec4}
===========================================================

*Clostridium niameyense* sp. nov. strain MT5 is the type strain of *C. niameyense* sp. nov., a new species within the genus *Clostridia.* The strain MT5 (= CSUR P1468 = DSMZ 100441), whose genome is described here, was isolated from a faecal sample collected from an anorexic patient with marasmus living in Nigeria. Optimal growth occurred at 37 °C, 24 hours after inoculation. The colonies were 0.1 to 0.3 mm in diameter on blood-enriched agar. *C. niameyense* is a Gram-positive, obligate anaerobic bacterium with a mean diameter of 1.3 μm.

*C. niameyense* has positive reactions for glycerol, erythritol, [d-]{.smallcaps}glucose, [d-]{.smallcaps}fructose, [d-]{.smallcaps}mannitol, [d-]{.smallcaps}saccharose, [d-]{.smallcaps}trehalose [d-]{.smallcaps}maltose, [d-]{.smallcaps}melezitose, amidone [d-]{.smallcaps}turanose and potassium 5-cétogluconate. Also, API ZYM presented positive reactions for α-glucosidase (maltase) and 17-β-glucosidase (cellulase).

*C. niameyense* is resistant to penicillin (14 mm), amoxicillin (13 mm), trimethoprim/sulfamethoxazole (6 mm), colistin (6 mm) and metronidazole (6 mm) but susceptible for another antibiotic.

The G+C content of the genome is 27.44%. The 16S rDNA and genome sequences are deposited in GenBank under accession numbers LN827532 and CVPI00000000, respectively. The type strain is MT5 (= CSUR P1468 = DSMZ 100441).
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[^1]: +, positive result; −, negative result; NA, data not available.

[^2]: COGs, Clusters of Orthologous Groups database.
